For example, in the humanized APP/PS1 double transgenic mouse model of AD that contains disease-associated mutations in the genes encoding APP and PSEN1, mice exhibit progressive Aβ plaque pathology accompanied by behavioral changes, including hyperactivity, deficits in sensorimotor gating, and the impairment of different types of memory [10–13]. The gene discussed is APP; the disease is Alzheimer disease.